---
figid: PMC7373735__fcell-08-00594-g001
figlink: pmc/articles/PMC7373735/figure/F1/
number: F1
caption: General mechanism of ferroptosis associated with lipid, amino acid, and iron
  metabolism. The inactive Fe3+ is delivered into the cell by TFR1 and reduced to
  Fe2+ in the endosome. Then, DMT1 transports Fe2+ to the labile iron pool (LIP).
  Autophagic degradation of ferritin (ferritinophagy) releases Fe2+ from ferritin,
  which is mediated by NCOA4. Fe2+ produces lipid ROS via the Fenton reaction and
  through the LOX pathway. Moreover, ACSL4 is required to activate polyunsaturated
  fatty acid, especially AA and AdA, to AA/AdA-CoA, then LPCAT3 catalyzes these derivatives
  and membrane PEs to form AA/AdA-PE, which are further converted into pro-ferroptotic
  lipid peroxidation under the activity of iron-containing LOXs. In conclusion, the
  Fenton reaction and oxidation of lipids facilitate the generation of lipid ROS,
  thus leading to ferroptosis. The system xc- is a cystine/glutamate antiporter. Intracellular
  cystine is reduced to cysteine for the biosynthesis of GSH. GPX4 converts two GSH
  molecules to GSSG each catalytic cycle to reduce lipid hydroperoxides, and then
  GSSG can be recycled back via GSH reductase in an NADPH-dependent manner. Ferroptosis
  inducers inhibit the GPX4-GSH-cysteine axis, thus inhibiting the reduction of lipid
  ROS. AA/AdA, arachidonic acid or adrenic acid; AA/AdA-CoA, arachidonic acid or adrenic
  acid coenzyme A; AA/AdA-PE, arachidonic acid or adrenic acid-phosphatidylethanolamine;
  AA/AdA-OOH-PE, arachidonic acid or adrenic acid-hydroperoxides-phosphatidylethanolamine;
  AA/AdA-OH-PE, arachidonic acid or adrenic acid-hydroxides-phosphatidylethanolamine;
  ACSL4, acyl-CoA synthetase long-chain family member 4; BSO, buthionine sulfoximine;
  CoA, coenzyme A; Cp, ceruloplasmin; Cys, L-cysteine; DMT1, divalent metal transporter
  1; Fer-1, ferrostatin-1; FPN, ferroportin; γ-GC, gamma-glutamylcysteine; γ-GCS,
  gamma-glutamylcysteine synthetase; Glu, L-glutamate; GPX4, glutathione peroxidase
  4; GR, glutathione reductase; GS, glutathione synthetase; GSH, reduced glutathione;
  GSSG, di-glutathione; LIP, labile iron pool; Lip-1, liproxstatin-1; LOX, lipoxygenase;
  LPCAT3, lysophosphatidylcholine acyltransferase 3; NCOA4, nuclear receptor coactivator
  4; PE, phosphatidylethanolamine; RSL3, RAS-selective lethal 3; STEAP3, 6-transmembrane
  epithelial antigen of the prostate 3; TF, transferrin; TFR1, transferrin receptor
  1.
pmcid: PMC7373735
papertitle: 'Ferroptosis in Acute Central Nervous System Injuries: The Future Direction?.'
reftext: Lesang Shen, et al. Front Cell Dev Biol. 2020;8:594.
pmc_ranked_result_index: '119850'
pathway_score: 0.9294921
filename: fcell-08-00594-g001.jpg
figtitle: General mechanism of ferroptosis associated with lipid, amino acid, and
  iron metabolism
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7373735__fcell-08-00594-g001.html
  '@type': Dataset
  description: General mechanism of ferroptosis associated with lipid, amino acid,
    and iron metabolism. The inactive Fe3+ is delivered into the cell by TFR1 and
    reduced to Fe2+ in the endosome. Then, DMT1 transports Fe2+ to the labile iron
    pool (LIP). Autophagic degradation of ferritin (ferritinophagy) releases Fe2+
    from ferritin, which is mediated by NCOA4. Fe2+ produces lipid ROS via the Fenton
    reaction and through the LOX pathway. Moreover, ACSL4 is required to activate
    polyunsaturated fatty acid, especially AA and AdA, to AA/AdA-CoA, then LPCAT3
    catalyzes these derivatives and membrane PEs to form AA/AdA-PE, which are further
    converted into pro-ferroptotic lipid peroxidation under the activity of iron-containing
    LOXs. In conclusion, the Fenton reaction and oxidation of lipids facilitate the
    generation of lipid ROS, thus leading to ferroptosis. The system xc- is a cystine/glutamate
    antiporter. Intracellular cystine is reduced to cysteine for the biosynthesis
    of GSH. GPX4 converts two GSH molecules to GSSG each catalytic cycle to reduce
    lipid hydroperoxides, and then GSSG can be recycled back via GSH reductase in
    an NADPH-dependent manner. Ferroptosis inducers inhibit the GPX4-GSH-cysteine
    axis, thus inhibiting the reduction of lipid ROS. AA/AdA, arachidonic acid or
    adrenic acid; AA/AdA-CoA, arachidonic acid or adrenic acid coenzyme A; AA/AdA-PE,
    arachidonic acid or adrenic acid-phosphatidylethanolamine; AA/AdA-OOH-PE, arachidonic
    acid or adrenic acid-hydroperoxides-phosphatidylethanolamine; AA/AdA-OH-PE, arachidonic
    acid or adrenic acid-hydroxides-phosphatidylethanolamine; ACSL4, acyl-CoA synthetase
    long-chain family member 4; BSO, buthionine sulfoximine; CoA, coenzyme A; Cp,
    ceruloplasmin; Cys, L-cysteine; DMT1, divalent metal transporter 1; Fer-1, ferrostatin-1;
    FPN, ferroportin; γ-GC, gamma-glutamylcysteine; γ-GCS, gamma-glutamylcysteine
    synthetase; Glu, L-glutamate; GPX4, glutathione peroxidase 4; GR, glutathione
    reductase; GS, glutathione synthetase; GSH, reduced glutathione; GSSG, di-glutathione;
    LIP, labile iron pool; Lip-1, liproxstatin-1; LOX, lipoxygenase; LPCAT3, lysophosphatidylcholine
    acyltransferase 3; NCOA4, nuclear receptor coactivator 4; PE, phosphatidylethanolamine;
    RSL3, RAS-selective lethal 3; STEAP3, 6-transmembrane epithelial antigen of the
    prostate 3; TF, transferrin; TFR1, transferrin receptor 1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CP
  - ADA
  - TFRC
  - ACSL1
  - ACSL3
  - ACSL4
  - ACSL5
  - ACSL6
  - SMG1
  - STEAP3
  - LPCAT3
  - LOX
  - NCOA4
  - GPX4
  - Fe
  - Cystine
  - Glutamate
  - Sorafenib
  - Sulfasalazine
  - FPN
  - Methionine
  - DFP
  - DFO,BPS
  - Cys
  - Vitamin E
  - BSO
  - acetaminophen
  - Glycine
  - AdA-0OH
  - GSH
  - NADP
  - OH
  - GSSG
  - NADPH
  - BPS
  - GS
  - Lip-1
genes:
- word: СР
  symbol: CP
  source: hgnc_symbol
  hgnc_symbol: CP
  entrez: '1356'
- word: AA/AdA
  symbol: ADA
  source: hgnc_symbol
  hgnc_symbol: ADA
  entrez: '100'
- word: TFR1
  symbol: TFR1
  source: hgnc_alias_symbol
  hgnc_symbol: TFRC
  entrez: '7037'
- word: ACSL
  symbol: ACSL
  source: bioentities_symbol
  hgnc_symbol: ACSL1
  entrez: '2180'
- word: ACSL
  symbol: ACSL
  source: bioentities_symbol
  hgnc_symbol: ACSL3
  entrez: '2181'
- word: ACSL
  symbol: ACSL
  source: bioentities_symbol
  hgnc_symbol: ACSL4
  entrez: '2182'
- word: ACSL
  symbol: ACSL
  source: bioentities_symbol
  hgnc_symbol: ACSL5
  entrez: '51703'
- word: ACSL
  symbol: ACSL
  source: bioentities_symbol
  hgnc_symbol: ACSL6
  entrez: '23305'
- word: LIP
  symbol: LIP
  source: hgnc_alias_symbol
  hgnc_symbol: SMG1
  entrez: '23049'
- word: STEAP3
  symbol: STEAP3
  source: hgnc_symbol
  hgnc_symbol: STEAP3
  entrez: '55240'
- word: LPCAT3
  symbol: LPCAT3
  source: hgnc_symbol
  hgnc_symbol: LPCAT3
  entrez: '10162'
- word: LOX
  symbol: LOX
  source: hgnc_symbol
  hgnc_symbol: LOX
  entrez: '4015'
- word: NCOA4
  symbol: NCOA4
  source: hgnc_symbol
  hgnc_symbol: NCOA4
  entrez: '8031'
- word: GPX4
  symbol: GPX4
  source: hgnc_symbol
  hgnc_symbol: GPX4
  entrez: '2879'
- word: LOX
  symbol: LOX
  source: hgnc_symbol
  hgnc_symbol: LOX
  entrez: '4015'
chemicals:
- word: Fe
  source: MESH
  identifier: D007501
- word: Cystine
  source: MESH
  identifier: D003553
- word: Glutamate
  source: ''
  identifier: ''
- word: Sorafenib
  source: MESH
  identifier: C471405
- word: Sulfasalazine
  source: MESH
  identifier: D012460
- word: FPN
  source: MESH
  identifier: C121101
- word: Methionine
  source: MESH
  identifier: D008715
- word: DFP
  source: MESH
  identifier: D007531
- word: DFO,BPS
  source: MESH
  identifier: C054233
- word: Cys
  source: MESH
  identifier: C046557
- word: Vitamin E
  source: MESH
  identifier: D014810
- word: BSO
  source: MESH
  identifier: C065566
- word: acetaminophen
  source: MESH
  identifier: D000082
- word: Glycine
  source: MESH
  identifier: D005998
- word: AdA-0OH
  source: MESH
  identifier: C467203
- word: GSH
  source: MESH
  identifier: D005978
- word: NADP
  source: MESH
  identifier: D009249
- word: OH
  source: MESH
  identifier: C031356
- word: GSSG
  source: MESH
  identifier: D019803
- word: NADPH
  source: MESH
  identifier: D009249
diseases:
- word: BPS
  source: MESH
  identifier: C564874
- word: GS
  source: MESH
  identifier: D011125
- word: Lip-1
  source: MESH
  identifier: D002971
figid_alias: PMC7373735__F1
redirect_from: /figures/PMC7373735__F1
figtype: Figure
---
